Featured Content
Live Webinars
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Live Virtual Webinar:
Saturday, July 19, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Live Virtual Webinar:
Saturday, April 12, 2025, at 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Live Virtual Webinar:
Saturday, March 8, 2025: 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT
Webcasts
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Released on 4/16/25
Expires on 4/16/26
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Released on 3/12/25
Expires on 3/12/26
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Released on 3/5/25
Expires on 3/5/26
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures
Released on 1/28/25
Expires on 1/28/26
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Released on 9/5/24
Expires on 9/5/25
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Released on 8/15/24
Expires on 8/15/25
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Released on 5/15/24
Expires on 5/15/25
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Released on 2/16/24
Expires on 2/16/25
Sustained-Release Drug Delivery System in the Management of Glaucoma
Released on 3/15/23
Expires on 3/15/24
Glaucoma: Sustained-release Drug Delivery System, Topical Agents, and Emerging 3D Visualization Technologies
Released on 3/1/23
Expires on 3/1/24